CVS Health (CVS) Announces Availability of Pfizer-BioNTech COVID-19 Vaccine to Children Aged 5-11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CVS Health (CVS) PT Raised to $115 at Cantor Fitzgerald
November 3, 2021 1:33 PM EDTCantor Fitzgerald analyst Steven Halper raised the price target on CVS Health (NYSE: CVS) to $115.00 (from $95.00) while maintaining an Overweight rating following earnings.
The analyst commented, "We reiterate our Overweight rating on CVS shares and increase our 12-month price target to $115 from $95.... More
CVS Health sees 2022 profit meeting Street estimates as COVID-19 costs subside
November 3, 2021 6:47 AM EDTBy Manas Mishra and Amruta Khandekar
(Reuters) -CVS Health Corp on Wednesday said its adjusted profit target for 2022 should largely meet Wall Street estimates, as it expects volatile medical costs in its health insurance unit to stabilize after the COVID-19 crisis drove them up this year.
Shares of the company, best-know for its drugstore chain, were up nearly 5%, as CVS also raised its 2021 profit forecast.
CVS now expects 2021 adjusted earnings per share of $7.90 to $8.00, up from its prior forecast of $7.70 to $7.80.
"We believe that... More
CVS Health (CVS) Tops Q3 EPS by 20c, Lifts FY EPS Guidance
November 3, 2021 6:37 AM EDTCVS Health (NYSE: CVS) reported Q3 EPS of $1.97, $0.20 better than the analyst estimate of $1.77. Revenue for the quarter came in at $73.79 billion versus the consensus estimate of $70.4 billion.
GUIDANCE:
CVS Health sees FY2021 EPS of $7.90-$8.00, versus the consensus of... More
Evine Live (EVLV) Appoints Mario Ramos as CFO
November 1, 2021 4:35 PM EDTEvolv Technology (NASDAQ: EVLV), the global leader in weapons detection security screening, today announced the appointment of Mario Ramos to the position of Chief Financial Officer effective November 1, 2021. Mr. Ramos will assume global responsibility for the Company's accounting, finance, risk compliance, information technology and investor relations functions.
Mr. Ramos joins Evolv Technology from Edelman Financial Engines where he served as Executive Vice President, Chief Financial Officer and Chief Risk Officer. Edelman Financial Engines is the nations top... More
